Contractibility sensor signal evolution predicts cardiovascular events in patients with cardiac resynchronization therapy.
CONCLUSIONS: In this first study publishing data on SonR™ signals in a real-life setting, SonR™ signal evolution over the first 6 months after cardiac resynchronization implantation was an independent predictor of cardiovascular events at follow-up. This variable could be useful to identify patients at higher risk of further adverse events after cardiac resynchronization implantation.
PMID: 30591324 [PubMed - as supplied by publisher]
Source: Archives of Cardiovascular Diseases - Category: Cardiology Authors: Garcia R, Guenancia C, Le Gal F, Rehman M, Tao V, Christiaens L, Ingrand P, Degand B Tags: Arch Cardiovasc Dis Source Type: research
More News: Arrhythmia | Cardiac Resynchronization Therapy | Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Heart Failure | Science | Study | Urology & Nephrology | Ventricular Arrhythmia